Skip to main content


Higher blood sugar levels cause damage over time to blood vessels and nerves, which can affect your eyes, heart, kidneys, and other organs. It’s important to be aware of these diabetes-related health complications so that you can act now to avoid them or prevent them from progressing.

FDA expands use to people with mild to moderate kidney disease.
People with type 2 diabetes should contact their physicians if symptoms of heart failure appear.
Making major improvements over current standard of care – how does this new treatment work? The FDA recently approved a new indication for a product that has been used...
People with type 2 diabetes should contact their physicians if they notice new pain, sores, or infections on their legs or feet.
A world-renowned researcher’s seven tips for expectant mothers with type 1, type 2, or gestational diabetes
Key lessons learned from one woman’s ongoing battle with adrenal insufficiency, and the unexpected role of diabetes technology.
How do I stay in range while sleeping?
Instead of “avoid long-term complications,” Adam Brown focuses on something more motivating and uplifting
An FDA advisory panel voted 17-2 to expand the drug label for type 2 diabetes drug Victoza to reflect a 13% reduction in overall heart risk and 22% reduction in heart-...
Full results of DEVOTE study presented at ADA 2017 show that basal insulin Tresiba reduces risk of severe hypoglycemia by 40% (by 53% overnight), in addition to being...
CANVAS study presented at ADA 2017 highlights heart and kidney protection for type 2 diabetes drug Invokana, and questions persist over an increased risk of amputations
Learn practical tips on taking care of your feet and how to easily make them a part of daily diabetes management
Information about diabetes supplies for those hit by the storms and for those who can help them
How to overcome the most frustrating diabetes landmine
FDA Approves New GLP-1 Label on Victoza to show that the medicine makes hearts healthier!
Key takeaways from the American Heart Association’s March 2017 conference in Portland, OR
Despite neutral heart outcome study results, the FDA added a warning for those at risk of heart failure
CVD-REAL study showed SGLT-2 inhibitors reduce the risk of hospitalization for heart failure in over 300,000 people with type 2 diabetes
Health Canada has approved the once-daily insulin for adults with type 1 and type 2 diabetes
FDA approves Lucentis for all types of diabetic retinopathy and IBM announces a new technology that helps doctors better diagnose retinopathy